Viewing Study NCT05885503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-25 @ 5:17 PM
Study NCT ID: NCT05885503
Status: RECRUITING
Last Update Posted: 2023-09-05
First Post: 2023-05-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema
Sponsor: RemeGen Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module